share_log

愛帝宮：截至二零二四年三月三十一日止股份發行人的證券變動月報表

AIDIGONG: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

香港交易所 ·  Apr 9 06:23
Summary by Moomoo AI
愛帝宮母嬰健康股份有限公司於2024年4月9日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的股份變動情況。報告顯示，公司的普通股股本結存維持在800,000,000港元，每股面值0.01港元，與上月相比無變動。優先股A類和B類的股本結存也分別保持在4,000,000港元，每股面值0.01港元，同樣未見增減。此外，公司已發行的可換股優先股A類和B類股份數目均為187,265,918股，並無本月內變動。根據2023年3月23日的條款，這些可換股優先股在未來30個月內可按一定比率轉換為普通股。公司確認，所有證券發行均已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的要求。
愛帝宮母嬰健康股份有限公司於2024年4月9日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的股份變動情況。報告顯示，公司的普通股股本結存維持在800,000,000港元，每股面值0.01港元，與上月相比無變動。優先股A類和B類的股本結存也分別保持在4,000,000港元，每股面值0.01港元，同樣未見增減。此外，公司已發行的可換股優先股A類和B類股份數目均為187,265,918股，並無本月內變動。根據2023年3月23日的條款，這些可換股優先股在未來30個月內可按一定比率轉換為普通股。公司確認，所有證券發行均已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的要求。
Royal Palace Maternal and Infant Health Co., Ltd. filed its latest Securities Change Month Report with Hong Kong Trading and Settlement Limited on April 9, 2024, reporting stock changes as of March 31, 2024. The report showed that the company's common share capital remained at HK$800,000,000 with a face value of HK$0.01 per share, unchanged from the previous month. Equity deposits for Class A and Class B shares were also maintained at HK$4,000,000, respectively, with a face value of HK$0.01 per share, and there was also no decrease. In addition, the number of convertible preferred shares Class A and Class B shares issued by the Company was 187,265,918 shares, unchanged during the month. Under the terms of March 23, 2023, these convertible preferred shares may be converted to ordinary shares at a certain ratio over the next 30 months. The Company confirms that all issuance of securities has been authorised by the Board of Directors and complies with the requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Royal Palace Maternal and Infant Health Co., Ltd. filed its latest Securities Change Month Report with Hong Kong Trading and Settlement Limited on April 9, 2024, reporting stock changes as of March 31, 2024. The report showed that the company's common share capital remained at HK$800,000,000 with a face value of HK$0.01 per share, unchanged from the previous month. Equity deposits for Class A and Class B shares were also maintained at HK$4,000,000, respectively, with a face value of HK$0.01 per share, and there was also no decrease. In addition, the number of convertible preferred shares Class A and Class B shares issued by the Company was 187,265,918 shares, unchanged during the month. Under the terms of March 23, 2023, these convertible preferred shares may be converted to ordinary shares at a certain ratio over the next 30 months. The Company confirms that all issuance of securities has been authorised by the Board of Directors and complies with the requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more